ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/25 | 2,426 | 2,459 | 2,394 | 2,445 | -5 | -0.2% | 807,600 |
2023/01/24 | 2,443 | 2,470 | 2,401 | 2,450 | -25 | -1% | 1,390,800 |
2023/01/23 | 2,375 | 2,515 | 2,371 | 2,475 | +121 | +5.1% | 3,058,100 |
2023/01/20 | 2,262 | 2,364 | 2,253 | 2,354 | +114 | +5.1% | 2,513,600 |
2023/01/19 | 2,160 | 2,264 | 2,158 | 2,240 | +72 | +3.3% | 1,566,500 |
2023/01/18 | 2,122 | 2,174 | 2,084 | 2,168 | +105 | +5.1% | 1,385,300 |
2023/01/17 | 2,170 | 2,179 | 2,057 | 2,063 | -116 | -5.3% | 1,526,200 |
2023/01/16 | 2,251 | 2,268 | 2,176 | 2,179 | -85 | -3.8% | 1,143,100 |
2023/01/13 | 2,250 | 2,288 | 2,245 | 2,264 | -2 | -0.1% | 538,900 |
2023/01/12 | 2,290 | 2,299 | 2,246 | 2,266 | -17 | -0.7% | 711,000 |
2023/01/11 | 2,258 | 2,310 | 2,249 | 2,283 | +62 | +2.8% | 1,411,500 |
2023/01/10 | 2,209 | 2,249 | 2,195 | 2,221 | +4 | +0.2% | 1,035,700 |
2023/01/06 | 2,177 | 2,226 | 2,167 | 2,217 | +60 | +2.8% | 1,096,000 |
2023/01/05 | 2,148 | 2,179 | 2,113 | 2,157 | +56 | +2.7% | 1,319,900 |
2023/01/04 | 2,161 | 2,176 | 2,091 | 2,101 | -37 | -1.7% | 1,031,500 |
2022/12/30 | 2,108 | 2,158 | 2,104 | 2,138 | +43 | +2.1% | 811,700 |
2022/12/29 | 2,080 | 2,104 | 2,066 | 2,095 | +31 | +1.5% | 529,200 |
2022/12/28 | 2,070 | 2,098 | 2,034 | 2,064 | -2 | -0.1% | 836,300 |
2022/12/27 | 2,054 | 2,119 | 2,053 | 2,066 | +3 | +0.1% | 798,900 |
2022/12/26 | 2,089 | 2,098 | 2,053 | 2,063 | -46 | -2.2% | 736,600 |
2022/12/23 | 2,087 | 2,129 | 2,073 | 2,109 | +22 | +1.1% | 839,100 |
2022/12/22 | 2,091 | 2,106 | 2,056 | 2,087 | -21 | -1% | 1,009,900 |
2022/12/21 | 2,121 | 2,160 | 2,089 | 2,108 | -6 | -0.3% | 1,188,400 |
2022/12/20 | 2,141 | 2,193 | 2,079 | 2,114 | -64 | -2.9% | 1,677,700 |
2022/12/19 | 2,193 | 2,214 | 2,167 | 2,178 | -44 | -2% | 1,413,800 |
2022/12/16 | 2,161 | 2,294 | 2,157 | 2,222 | +172 | +8.4% | 5,166,900 |
2022/12/15 | 2,028 | 2,087 | 2,000 | 2,050 | +20 | +1% | 922,200 |
2022/12/14 | 2,033 | 2,083 | 2,024 | 2,030 | +6 | +0.3% | 904,900 |
2022/12/13 | 1,990 | 2,048 | 1,983 | 2,024 | +73 | +3.7% | 1,457,300 |
2022/12/12 | 1,959 | 1,969 | 1,939 | 1,951 | -32 | -1.6% | 529,300 |
2022/12/09 | 1,960 | 1,989 | 1,952 | 1,983 | +30 | +1.5% | 726,000 |
2022/12/08 | 1,945 | 1,961 | 1,928 | 1,953 | +21 | +1.1% | 596,400 |
2022/12/07 | 1,886 | 1,947 | 1,885 | 1,932 | +34 | +1.8% | 721,000 |
2022/12/06 | 1,871 | 1,929 | 1,867 | 1,898 | +21 | +1.1% | 632,300 |
2022/12/05 | 1,841 | 1,888 | 1,836 | 1,877 | +23 | +1.2% | 399,900 |
2022/12/02 | 1,888 | 1,888 | 1,844 | 1,854 | -27 | -1.4% | 605,800 |
2022/12/01 | 1,936 | 1,948 | 1,870 | 1,881 | -15 | -0.8% | 733,000 |
2022/11/30 | 1,944 | 1,957 | 1,890 | 1,896 | -68 | -3.5% | 812,400 |
2022/11/29 | 1,904 | 1,976 | 1,886 | 1,964 | +48 | +2.5% | 1,103,000 |
2022/11/28 | 1,904 | 1,980 | 1,899 | 1,916 | +83 | +4.5% | 1,636,000 |
2022/11/25 | 1,874 | 1,880 | 1,808 | 1,833 | -51 | -2.7% | 1,210,800 |
2022/11/24 | 1,918 | 1,935 | 1,879 | 1,884 | -23 | -1.2% | 986,500 |
2022/11/22 | 1,918 | 1,937 | 1,890 | 1,907 | -16 | -0.8% | 824,500 |
2022/11/21 | 1,980 | 1,980 | 1,923 | 1,923 | -37 | -1.9% | 632,500 |
2022/11/18 | 1,975 | 1,982 | 1,947 | 1,960 | -20 | -1% | 734,000 |
2022/11/17 | 2,000 | 2,014 | 1,975 | 1,980 | -44 | -2.2% | 774,000 |
2022/11/16 | 2,049 | 2,070 | 1,995 | 2,024 | -23 | -1.1% | 1,107,300 |
2022/11/15 | 1,950 | 2,060 | 1,946 | 2,047 | +126 | +6.6% | 1,773,000 |
2022/11/14 | 1,940 | 2,009 | 1,915 | 1,921 | -17 | -0.9% | 1,554,300 |
2022/11/11 | 1,950 | 1,961 | 1,907 | 1,938 | +12 | +0.6% | 832,800 |
451~
500
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.27倍 | 1.47倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム